Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Huntersville, NC
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Huntersville, NC
Click here to add this to my saved trials
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated:  4/2/2018
Novartis Investigative Site
mi
from
Lodz,
A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
A Randomized, Double Blind, Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Multiple Doses of QBW251 in Patients With COPD
Status: Enrolling
Updated: 4/2/2018
Novartis Investigative Site
mi
from
Lodz,
Click here to add this to my saved trials
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers
Status: Enrolling
Updated:  4/3/2018
Wayne State University
mi
from
Detroit, MI
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC)
Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers
Status: Enrolling
Updated: 4/3/2018
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Status: Enrolling
Updated:  4/3/2018
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
Status: Enrolling
Updated: 4/3/2018
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults
Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults
Status: Enrolling
Updated:  4/3/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults
Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults
Status: Enrolling
Updated: 4/3/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure
The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure
Status: Enrolling
Updated:  4/3/2018
Ohio State University
mi
from
Columbus, OH
The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure
The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure
Status: Enrolling
Updated: 4/3/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Status: Enrolling
Updated:  4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study
Status: Enrolling
Updated: 4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effect of Clonidine on Responses to Imagery Scripts
Effect of Clonidine on Responses to Imagery Scripts
Status: Enrolling
Updated:  4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Effect of Clonidine on Responses to Imagery Scripts
Effect of Clonidine on Responses to Imagery Scripts
Status: Enrolling
Updated: 4/4/2018
National Institute on Drug Abuse
mi
from
Baltimore, MD
Click here to add this to my saved trials
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Status: Enrolling
Updated:  4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Montelukast to Treat Bronchiolitis Obliterans
Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults
Status: Enrolling
Updated:  4/6/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Montelukast to Treat Bronchiolitis Obliterans
Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults
Status: Enrolling
Updated: 4/6/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
Evaluating the Feasibility of Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
Status: Enrolling
Updated:  4/6/2018
Pediatric Diagnostic Center
mi
from
Ventura, CA
Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
Evaluating the Feasibility of Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
Status: Enrolling
Updated: 4/6/2018
Pediatric Diagnostic Center
mi
from
Ventura, CA
Click here to add this to my saved trials
Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
Randomized Controlled Study of Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Hospitalized Patients With Exacerbation of Cystic Fibrosis
Status: Enrolling
Updated:  4/9/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
Randomized Controlled Study of Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Hospitalized Patients With Exacerbation of Cystic Fibrosis
Status: Enrolling
Updated: 4/9/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)
Study of Cardiac MRI to Assess Pulmonary Perfusion and Pulmonary Hemodynamics in Patients With Cystic Fibrosis Study (Pilot 3)
Status: Enrolling
Updated:  4/9/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)
Study of Cardiac MRI to Assess Pulmonary Perfusion and Pulmonary Hemodynamics in Patients With Cystic Fibrosis Study (Pilot 3)
Status: Enrolling
Updated: 4/9/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease
Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease Using the ESAS-Sarcoma Modified Questionnaire
Status: Enrolling
Updated:  4/9/2018
Duke University Health System
mi
from
Durham, NC
Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease
Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease Using the ESAS-Sarcoma Modified Questionnaire
Status: Enrolling
Updated: 4/9/2018
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
Improving the Frequency and Quality of Sleep Apnea Care Management
Improving the Frequency and Quality of Sleep Apnea Care Management
Status: Enrolling
Updated:  4/10/2018
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Improving the Frequency and Quality of Sleep Apnea Care Management
Improving the Frequency and Quality of Sleep Apnea Care Management
Status: Enrolling
Updated: 4/10/2018
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
Airway Muscle Training for Obstructive Sleep Apnea
Upper Airway Muscle Training for Obstructive Sleep Apnea
Status: Enrolling
Updated:  4/10/2018
UFHealth Sleep Center
mi
from
Gainesville, FL
Airway Muscle Training for Obstructive Sleep Apnea
Upper Airway Muscle Training for Obstructive Sleep Apnea
Status: Enrolling
Updated: 4/10/2018
UFHealth Sleep Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Status: Enrolling
Updated:  4/17/2018
Children's Hospital at Montefiore
mi
from
Bronx, NY
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
Status: Enrolling
Updated: 4/17/2018
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Status: Enrolling
Updated:  4/18/2018
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Acute Exacerbation of COPD and Physical Activity - Preliminary Study
Status: Enrolling
Updated: 4/18/2018
University of Michigan, School of Nursing
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Tolerance and Acute Effects of Humidified Nasal High-flow With Oxygen (HNHF-O2) on Gas Exchange in Patients Hospitalized With an Acute Exacerbation of COPD
Status: Enrolling
Updated:  4/18/2018
Temple University Hospital
mi
from
Philadelphia, PA
Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Tolerance and Acute Effects of Humidified Nasal High-flow With Oxygen (HNHF-O2) on Gas Exchange in Patients Hospitalized With an Acute Exacerbation of COPD
Status: Enrolling
Updated: 4/18/2018
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Status: Enrolling
Updated:  4/18/2018
National Jewish Health
mi
from
Denver, CO
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
Status: Enrolling
Updated: 4/18/2018
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Controlled Ventilation CT in CF Infants
Differentiating Outcome Measures in Infants/Young Children With Cystic Fibrosis Utilizing Controlled Ventilation Infant/Young Child Chest CT Scanning and Lung Function Testing
Status: Enrolling
Updated:  4/20/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Controlled Ventilation CT in CF Infants
Differentiating Outcome Measures in Infants/Young Children With Cystic Fibrosis Utilizing Controlled Ventilation Infant/Young Child Chest CT Scanning and Lung Function Testing
Status: Enrolling
Updated: 4/20/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated:  4/20/2018
Sequoia Sleep Diagnostics
mi
from
Fresno, CA
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated: 4/20/2018
Sequoia Sleep Diagnostics
mi
from
Fresno, CA
Click here to add this to my saved trials
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated:  4/20/2018
Complete Sleep Solutions
mi
from
Murrieta, CA
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated: 4/20/2018
Complete Sleep Solutions
mi
from
Murrieta, CA
Click here to add this to my saved trials
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated:  4/20/2018
Broward Research Group
mi
from
Hollywood, FL
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated: 4/20/2018
Broward Research Group
mi
from
Hollywood, FL
Click here to add this to my saved trials
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated:  4/20/2018
Clinilabs Inc.
mi
from
New York, NY
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated: 4/20/2018
Clinilabs Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated:  4/20/2018
SleepMed of South Carolina
mi
from
Columbia, SC
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Non-Inferiority Study of the FRESCA Mask Versus Existing CPAP Mask for Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated: 4/20/2018
SleepMed of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function
Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function
Status: Enrolling
Updated:  4/24/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function
Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function
Status: Enrolling
Updated: 4/24/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Intervention for Improving Asthma Care for Minority Children in Head Start
Improving Asthma Care for Minority Children in Head Start
Status: Enrolling
Updated:  4/24/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Intervention for Improving Asthma Care for Minority Children in Head Start
Improving Asthma Care for Minority Children in Head Start
Status: Enrolling
Updated: 4/24/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Dothan, AL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Huntsville, AL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Sheffield, AL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Sheffield, AL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Flagstaff, AZ
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Flagstaff, AZ
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Costa Mesa, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Gold River, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Gold River, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Lincoln, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Lincoln, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Long Beach, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Palo Alto, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
San Diego, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Upland, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Yorba Linda, CA
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Yorba Linda, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Boulder, CO
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Denver, CO
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
New Haven, CT
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Chiefland, FL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Chiefland, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Clearwater, FL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Hialeah, FL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated:  4/26/2018
Clinical Research Facility
mi
from
Kissimmee, FL
A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)
A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Status: Enrolling
Updated: 4/26/2018
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials